Biomarker Detection
Antibodies, ELISA kits, standards and controls for RCC marker studies.
Renal Tumor Research · RCC Biomarkers · Molecular Oncology Tools
Kidney Cancer Research Products
Explore research-use products for kidney tumor biology, renal cell carcinoma, clear cell RCC, VHL/HIF signaling, VEGF angiogenesis, mTOR biology, immune checkpoint pathways, tumor metabolism, invasion, metastasis and experimental drug-response workflows.
Products and content are intended for research and educational use only.
They are not presented as diagnostic, therapeutic or medical-use products.
VHL
HIF
VEGF
CAIX
PD-L1
Research Categories
Kidney cancer research product categories
Build renal tumor research workflows with antibodies, assay kits, proteins, cell-culture tools, molecular reagents and functional assay systems.
01
Antibodies
RCC & Kidney Tumor Antibodies
Primary antibodies for VHL, HIF-1α, HIF-2α, VEGF, VEGFR, CAIX, CD10, PAX8, RCC marker, Ki-67, PD-L1 and renal tumor microenvironment studies.
View antibodies
02
ELISA
ELISA Kits & Quantitative Assays
Kits for VEGF, cytokines, growth factors, inflammatory markers, soluble immune mediators and renal tumor-associated analytes.
View ELISA kits
03
Proteins
Recombinant Proteins & Standards
Recombinant proteins, calibrators and standards for assay development, antibody validation, pathway stimulation and control experiments.
View proteins
04
Molecular
DNA, RNA & qPCR Tools
Molecular workflow reagents for VHL, HIF signaling, mTOR pathway studies, RCC subtype profiling and gene-expression research.
View molecular tools
05
Cells
Cell Culture & Model Reagents
Media, supplements, matrices, transfection reagents and culture tools for renal tumor cell models, spheroids and functional biology studies.
View culture tools
06
Assays
Viability, Hypoxia & Drug Response
ATP, cytotoxicity, apoptosis, proliferation, oxidative stress, hypoxia, migration and invasion assays for RCC experimental workflows.
View assay tools
Biomarker Constellation
Important kidney cancer research biomarkers
Kidney cancer research often focuses on oxygen sensing, angiogenesis, immune response, metabolism, RCC subtype identity and renal tumor progression.
VHL
Oxygen-sensing biology
Widely studied in clear cell RCC and hypoxia-response pathway research.
HIF
Hypoxia signaling
HIF-1α and HIF-2α are studied in oxygen adaptation, metabolism and angiogenesis.
VEGF
Angiogenesis
VEGF and VEGFR pathways support vascular growth in many RCC research models.
CAIX
Clear cell RCC marker
CAIX is commonly studied as a hypoxia-associated marker in clear cell RCC biology.
Renal Tumor Markers
VHL
HIF-2α
VEGF
CAIX
mTOR
PD-L1
Workflow Selector
Select products by kidney cancer workflow
Choose the experimental workflow and highlight matching product groups for RCC research.
IHC / Tissue Research
Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, PAX8, CAIX, CD10, RCC marker, Ki-67, PD-L1, vascular markers and immune-infiltration markers.
Browse tissue research products
Applications
Applications in kidney cancer research
Use kidney tumor research products across biomarker discovery, assay validation, subtype research, immune profiling and experimental treatment-response models.
Clear cell RCC biology
Study VHL/HIF, CAIX, angiogenesis, metabolism and lipid-rich tumor biology.
Hypoxia and angiogenesis
Measure HIF, VEGF, VEGFR, vessel markers and oxygen-response pathways.
Immune microenvironment
Analyze PD-1, PD-L1, T-cell markers, macrophages, cytokines and inflammation.
mTOR and metabolism
Study nutrient sensing, growth control, protein synthesis and metabolic adaptation.
Migration and invasion
Investigate matrix remodeling, motility, EMT-like changes and metastatic potential.
Drug-response studies
Measure viability, apoptosis, cytotoxicity, hypoxia response and pathway inhibition.
Product Match
Target
Subtype
Sample
Assay
Controls
Selection Guide
How to choose kidney cancer research products
Product selection should match the target biology, RCC subtype, sample type, assay format and validation requirements.
Define the RCC biology question
Examples: VHL/HIF signaling, angiogenesis, immune checkpoints, mTOR, invasion or drug response.
Match the sample type
Review compatibility with FFPE tissue, frozen tissue, serum, plasma, urine, cell lysates or cultured cells.
Check assay compatibility
Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.
Use controls and standards
Include positive controls, negative controls, calibrators, reference samples and reproducibility checks.
Browse kidney tumor research products
Explore research-use tools for renal cell carcinoma biomarkers, kidney tumor biology, molecular oncology, tissue studies, immune profiling and experimental models.
FAQ
FAQ: Kidney Cancer Research Products
Clear answers to common product-selection and kidney tumor workflow questions.
What are kidney cancer research products?
Kidney cancer research products are laboratory-use reagents and assay tools used to study renal tumor biology, RCC biomarkers, angiogenesis, immune response, molecular pathways, metastasis and experimental treatment response.
Which biomarkers are commonly studied in kidney cancer research?
Frequently studied biomarkers include VHL, HIF-1α, HIF-2α, VEGF, VEGFR, CAIX, CD10, PAX8, RCC marker, Ki-67, mTOR, AKT, PD-1 and PD-L1.
Which products are used for kidney tumor tissue studies?
Tissue-based kidney tumor studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, subtype markers, vascular markers and immune microenvironment markers.
Are these products for diagnostic or therapeutic use?
No. The products described on this page are presented for research use only unless an individual product page clearly states otherwise.
References
Scientific References
Authoritative sources supporting kidney cancer biology, biomarkers and research context.
- NCBI Bookshelf / renal physiology resources for kidney biological context.
- Renal cell carcinoma research literature on VHL/HIF and VEGF angiogenesis pathways.
- Kidney cancer research literature on mTOR signaling and tumor metabolism.
- Renal tumor microenvironment research on immune markers and checkpoint biology.
- RCC subtype research literature covering clear cell, papillary and chromophobe RCC.